Cargando…
Emerging roles of m6A RNA modification in cancer therapeutic resistance
Marvelous advancements have been made in cancer therapies to improve clinical outcomes over the years. However, therapeutic resistance has always been a major difficulty in cancer therapy, with extremely complicated mechanisms remain elusive. N6-methyladenosine (m6A) RNA modification, a hotspot in e...
Autores principales: | Liu, Wei-Wei, Zhang, Zhong-Yuan, Wang, Fei, Wang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942381/ https://www.ncbi.nlm.nih.gov/pubmed/36810281 http://dx.doi.org/10.1186/s40164-023-00386-2 |
Ejemplares similares
-
The Emerging Role of m6A Modification in Endocrine Cancer
por: Ji, Xiaoyu, et al.
Publicado: (2023) -
The Pivotal Role of Chemical Modifications in mRNA Therapeutics
por: Liu, Albert, et al.
Publicado: (2022) -
Roles of N(6)-methyladenosine (m(6)A) modifications in gynecologic cancers: mechanisms and therapeutic targeting
por: Chen, Jiahua, et al.
Publicado: (2022) -
The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022) -
The Complex Roles and Therapeutic Implications of m(6)A Modifications in Breast Cancer
por: Wei, Min, et al.
Publicado: (2021)